Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.47 USD | -3.23% | -0.94% | +63.84% |
May. 20 | Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing | MT |
May. 14 | Enliven Therapeutics Q1 Loss Narrows | MT |